![]() Liminatus Pharma Liminatus Pharma (formerly known as Iris Acquisition) is a pre‑clinical‑stage immuno‑oncology company. | ![]() CEL-SCI CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases. | ![]() Topas Therapeutics Topas Therapeutics is a development stage company that intends to build neuro based pipeline of clinical-stage development therapeutics and projects to treat autoimmune diseases such as multiple sclerosis. | ![]() SingletO2 Therapeutics SingletO2 Therapeutics is a company engaged in developing treatments for periodontal disease. | ONCOtherapeutics ONCOtherapeutics is a contract research organization that runs multiple clinical trials. | |
Founding Date | Founding Date 2018 | Founding Date 1983 | Founding Date 2013 | Founding Date 2015 | Founding Date 2005 |
Type | Type Public | Type Public | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations La Palma, US HQ | Locations Vienna, US HQ | Locations Hamburg, DE HQ Bremen, DE | Locations Summit, US HQ | Locations West Hollywood, US HQ |
Employees | Employees 1 | Employees N/A | Employees N/A | Employees 2 | Employees 13 |
Financial | |||||
Net income | Net income ($10.2m) (FY, 2025) | Net income ($25.4m) (FY, 2025) | Net income N/A | Net income N/A | Net income N/A |

CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
View company
Topas Therapeutics is a development stage company that intends to build neuro based pipeline of clinical-stage development therapeutics and projects to treat autoimmune diseases such as multiple sclerosis.
View company
SingletO2 Therapeutics is a company engaged in developing treatments for periodontal disease.
View companyONCOtherapeutics is a contract research organization that runs multiple clinical trials.
View company